166 related articles for article (PubMed ID: 33127342)
1. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
[TBL] [Abstract][Full Text] [Related]
2. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
3. SETD8 is a prognostic biomarker that contributes to stem-like cell properties in non-small cell lung cancer.
Piao L; Feng Y; Che N; Li M; Li X; Jin Y; Xuan Y
Pathol Res Pract; 2020 Dec; 216(12):153258. PubMed ID: 33130499
[TBL] [Abstract][Full Text] [Related]
4. Gli1 regulates stemness characteristics in gastric adenocarcinoma.
Qi W; Yang Z; Feng Y; Li H; Che N; Liu L; Xuan Y
Diagn Pathol; 2020 May; 15(1):60. PubMed ID: 32430068
[TBL] [Abstract][Full Text] [Related]
5. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.
Piao L; Feng Y; Yang Z; Qi W; Li H; Han H; Xuan Y
Pathol Res Pract; 2019 Jul; 215(7):152437. PubMed ID: 31101574
[TBL] [Abstract][Full Text] [Related]
6. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
7. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
[TBL] [Abstract][Full Text] [Related]
8. Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway.
Liu Y; Chen H; Xiao L; Dong P; Ma Y; Zhou Y; Yang J; Bian B; Xie G; Chen L; Shen L
Cell Oncol (Dordr); 2024 Apr; 47(2):463-480. PubMed ID: 37749430
[TBL] [Abstract][Full Text] [Related]
9. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
[TBL] [Abstract][Full Text] [Related]
10. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
[TBL] [Abstract][Full Text] [Related]
11. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
[TBL] [Abstract][Full Text] [Related]
12. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
[TBL] [Abstract][Full Text] [Related]
16. Gastric Adenocarcinoma Biomarker Expression Profiles and their Prognostic Value.
Senol S; Aydin A; Kosemetin D; Ece D; Akalin I; Abuoglu H; Duran EA; Aydin D; Erkol B
J Environ Pathol Toxicol Oncol; 2016; 35(3):207-222. PubMed ID: 27910777
[TBL] [Abstract][Full Text] [Related]
17. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability.
Xiao Y; Pan J; Geng Q; Wang G
FEBS Open Bio; 2019 Jul; 9(7):1212-1222. PubMed ID: 31037832
[TBL] [Abstract][Full Text] [Related]
19. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
20. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
Li X; Liu Z; Xia C; Yan K; Fang Z; Fan Y
Cancer Lett; 2022 Feb; 527():150-163. PubMed ID: 34942305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
